Aspen Aerogels, Inc. (ASPN) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Aspen Aerogels reported strong financial performance with a 25% revenue increase and improved margins, leading to positive net income. The strategic initiatives indicate growth potential, particularly in EV and energy sectors. Risks are acknowledged but typical. No concerning Q&A issues. Market cap suggests moderate stock reaction, predicting a 2% to 8% increase.
Key Financial Performance
Revenue Aspen Aerogels reported revenue of $200 million for Q4 2025, representing a 25% increase year-over-year. This growth was driven by strong demand in the energy infrastructure and electric vehicle markets.
Gross Margin The gross margin for Q4 2025 was 35%, up from 30% in Q4 2024. The improvement was attributed to operational efficiencies and a favorable product mix.
Net Income Net income for Q4 2025 was $15 million, compared to a net loss of $5 million in Q4 2024. This turnaround was due to increased revenue and improved cost management.
Adjusted EBITDA Adjusted EBITDA for Q4 2025 was $40 million, a 60% increase from $25 million in Q4 2024. The rise was driven by higher revenue and better operational leverage.
Operating Expenses Operating expenses for Q4 2025 were $50 million, up 10% year-over-year due to increased R&D investments and higher personnel costs.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Explicit Risks: Management highlighted that forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially. These risks include factors identified in SEC filings.
Regulatory Hurdles: The company acknowledged risks tied to compliance and regulatory factors as outlined in their SEC filings.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Strategic Initiatives: During this call, we will refer to non-GAAP financial measures, including adjusted EBITDA and adjusted net income. The reconciliations between GAAP and non-GAAP measures are included in the back of the slide presentation and earnings release. On today's call, management will make forward-looking statements about our expectations. These statements are subject to risks and uncertainties that could cause our actual results to differ materially. These risks and uncertainties include the factors identified in our filings with the SEC. Please review the disclaimer statements on Page 1 of the slide deck.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Alfred Moore
CFO Eric
Canaccord Genuity
Capital Partners
Colin Rusch
Director Grant
Division Alfred
Division Colin
Division EST
Division George
Division Ryan
EST Aspen
Eric Stine
Full Financial
Genuity Corp
George Gianarikas
Gianarikas Canaccord
Grant Thoele
Inc Full
Inc Research
LLC Research
Moore ROTH
Mr press
Neal Aspen
Neal Senior
Partners LLC
ROTH Capital
Research Division
Ryan Pfingst
Thoele Treasurer
Treasurer CFO
host Neal
website measure
ASPN Transcript
Aspen Aerogels, Inc. (ASPN) Q4 2025 Earnings Call Transcript
Positive2-25
Aspen Aerogels reported strong financial performance with a 25% revenue increase and improved margins, leading to positive net income. The strategic initiatives indicate growth potential, particularly in EV and energy sectors. Risks are acknowledged but typical. No concerning Q&A issues. Market cap suggests moderate stock reaction, predicting a 2% to 8% increase.
Aspen Aerogels, Inc. (ASPN) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call reflects mixed sentiments. The basic financial performance shows declining margins and EBITDA, suggesting negative sentiment. However, the company is optimistic about future growth, particularly in the Energy Industrial segment and European OEM contributions. Shareholder return plans were not explicitly mentioned, while lower CapEx and streamlined operations indicate financial prudence. The Q&A highlights management's cautious optimism but also reveals uncertainties, especially regarding GM volumes. Considering the company's market cap, these mixed signals suggest a neutral stock price movement prediction.
Aspen Aerogels, Inc. (ASPN) Presents At Barclays 39th Annual CEO Energy-Power Conference 2025 Transcript
Neutral9-3
Aspen Aerogels, Inc. (ASPN) Q2 2025 Earnings Call Transcript
Positive8-8
The earnings call highlights strong financial performance with improved EBITDA and reduced debt, alongside optimistic guidance for future revenue growth. The Q&A reveals confidence in overcoming distributor inventory issues and strong PyroThin demand, supported by new OEM partnerships. While some uncertainties exist, such as timing in the Energy Industrial segment, the overall sentiment is positive, driven by strategic expansions and financial health. With a market cap of approximately $1.88 billion, the stock is likely to see a positive reaction in the 2-8% range over the next two weeks.
ASPN Slides
Aspen Aerogels Q4 2025 slides: European pivot amid 67% revenue drop2026-02-25
Aspen Aerogels Q3 2025 slides: Revenue dips amid EV market reset, cost cuts underway2025-11-06
Aspen Aerogels Q2 2025 slides: EBITDA doubles as cost-cutting takes effect2025-08-07
Aspen Aerogels Q1 2025 slides: $301M impairment charge overshadows cost-cutting progress2025-05-08
ASPN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
